Swiss National Bank
MGNX icon

Swiss National Bank’s MacroGenics MGNX Stock Holding History

Swiss National Bank’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-91,800
Closed -$390K – 2478
2024
Q2 		$390K Hold
91,800
– – ﹤0.01% 2439
2024
Q1 		$1.35M Buy
+91,800
New +$1.39M ﹤0.01% 2066
2022
Q4 		– Sell
-93,900
Closed -$325K – 2706
2022
Q3 		$325K Hold
93,900
– – ﹤0.01% 2660
2022
Q2 		$277K Sell
93,900
-21,900
-19% -$115K ﹤0.01% 2714
2022
Q1 		$1.02M Buy
115,800
+8,200
+8% +$90.5K ﹤0.01% 2397
2021
Q4 		$1.73M Buy
107,600
+1,500
+1% +$28.2K ﹤0.01% 2159
2021
Q3 		$2.22M Buy
106,100
+6,900
+7% +$166K ﹤0.01% 1989
2021
Q2 		$2.67M Sell
99,200
-22,800
-19% -$668K ﹤0.01% 1913
2021
Q1 		$3.89M Buy
122,000
+5,800
+5% +$141K ﹤0.01% 1607
2020
Q4 		$2.66M Buy
116,200
+10,400
+10% +$239K ﹤0.01% 1750
2020
Q3 		$2.67M Buy
105,800
+1,900
+2% +$51.9K ﹤0.01% 1568
2020
Q2 		$2.9M Buy
103,900
+13,800
+15% +$240K ﹤0.01% 1496
2020
Q1 		$524K Buy
90,100
+1,200
+1% +$10.9K ﹤0.01% 2155
2019
Q4 		$967K Buy
88,900
+2,700
+3% +$26.7K ﹤0.01% 2156
2019
Q3 		$1.1M Hold
86,200
– – ﹤0.01% 2007
2019
Q2 		$1.46M Buy
86,200
+3,500
+4% +$60.1K ﹤0.01% 1891
2019
Q1 		$1.49M Buy
82,700
+15,500
+23% +$268K ﹤0.01% 1848
2018
Q4 		$853K Buy
67,200
+2,500
+4% +$41.9K ﹤0.01% 2095
2018
Q3 		$1.39M Hold
64,700
– – ﹤0.01% 1956
2018
Q2 		$1.34M Hold
64,700
– – ﹤0.01% 1985
2018
Q1 		$1.63M Buy
64,700
+5,100
+9% +$124K ﹤0.01% 1773
2017
Q4 		$1.13M Buy
59,600
+4,400
+8% +$82.1K ﹤0.01% 2014
2017
Q3 		$1.02M Hold
55,200
– – ﹤0.01% 2056
2017
Q2 		$967K Buy
55,200
+9,200
+20% +$175K ﹤0.01% 2076
2017
Q1 		$856K Buy
46,000
+2,400
+6% +$46.3K ﹤0.01% 2127
2016
Q4 		$891K Hold
43,600
– – ﹤0.01% 2110
2016
Q3 		$1.3M Sell
43,600
-1,400
-3% -$41.6K ﹤0.01% 1804
2016
Q2 		$1.22M Buy
45,000
+1,400
+3% +$31.6K ﹤0.01% 1850
2016
Q1 		$789K Buy
43,600
+8,300
+24% +$158K ﹤0.01% 2052
2015
Q4 		$1.09M Hold
35,300
– – ﹤0.01% 1761
2015
Q3 		$756K Buy
35,300
+7,200
+26% +$226K ﹤0.01% 1952
2015
Q2 		$1.07M Buy
28,100
+4,900
+21% +$161K ﹤0.01% 1755
2015
Q1 		$728K Hold
23,200
– – ﹤0.01% 1943
2014
Q4 		$814K Hold
23,200
– – ﹤0.01% 1849
2014
Q3 		$485K Buy
23,200
+7,000
+43% +$145K ﹤0.01% 2123
2014
Q2 		$352K Buy
+16,200
New +$341K ﹤0.01% 2329

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swiss National Bank's MGNX Position: Q3 2024 in Review

Swiss National Bank sold out of MacroGenics (MGNX) in Q3 2024, closing a stake of 91,800 shares — an estimated $390K sold.

Swiss National Bank first reported a position in MGNX in Q2 2014 and held it in 36 quarters. The position peaked at $3.89M in Q1 2021. 124 funds tracked by Wall St. Rank hold MGNX as of Q3 2024.

  • Swiss National Bank reported no remaining MacroGenics position as of Q3 2024 after selling out during the quarter.
  • Swiss National Bank sold 91,800 MacroGenics shares in Q3 2024, an estimated $390K.
  • Swiss National Bank first reported a position in MacroGenics in Q2 2014 and held it in 36 quarters.
  • Swiss National Bank's MacroGenics position peaked at $3.89M in Q1 2021.
  • 124 funds tracked by Wall St. Rank held MacroGenics as of Q3 2024.

Based on Swiss National Bank's 13F filing for Q3 2024, filed 7 Nov 2024.